2010•Guoji yaoxue yanjiu zazhiRequires access

Bioequivalence of bicalutamide tablet in healthy volunteers

Shao Qing-xiang

Open publisher page 0 citations

Abstract

Objective To study the pharmacokinetic characteristics and bioequivalence of bicalutamide tablets in healthy volunteers.Methods A single oral dose of 50 mg bicalutamide test(domestic)or control(import)tablets was given to 20 healthy volunteers in an open randomized cross-over study.The concentrations of bicalutamide were determined with HPLC.The pharmacokinetic parameters were calculated with 3P97 and the bioequivalent test was performed with SAS.Results The main pharmacokinetic parameters of the test and control drug were as follows:Cmax,691.50 vs 697.30 μg/L;Tmax,20.65 vs 24.10 h;AUC0~∞,148 124 vs 153 782 μg·h/L;t1/2,127.46 vs 131.06 h,respectively.The relative bioavailability was 99.43%.Conclusion The test bicalutamide tablet is bioequivalent to the control formulation.

About this research paper

What this paper is about

Objective To study the pharmacokinetic characteristics and bioequivalence of bicalutamide tablets in healthy volunteers.Methods A single oral dose of 50 mg bicalutamide test(domestic)or control(import)tablets was given to 20 healthy volunteers in an open randomized cross-over study.The concentrations of bicalutamide were determined with HPLC.The pharmacokinetic parameters were calculated with 3P97 and the bioequivalent test was performed with SAS.Results The main pharmacokinetic parameters of the test and control drug were as follows:Cmax,691.50 vs 697.30 μg/L;Tmax,20.65 vs 24.10 h;AUC0~∞,148 124 vs 153 782 μg·h/L;t1/2,127.46 vs 131.06 h,respectively.The relative bioavailability was 99.43%.Conclusion The test bicalutamide tablet is bioequivalent to the control formulation.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the pharmacokinetic characteristics and bioequivalence of bicalutamide tablets in healthy volunteers.Methods A single oral dose of 50 mg bicalutamide test(domestic)or control(import)tablets was given to 20 healthy volunteers in an open randomized cross-over study.The concentrations of bicalutamide were determined with HPLC.The pharmacokinetic parameters were calculated with 3P97 and the bioequivalent test was performed with SAS.Results The main pharmacokinetic parameters of the test and control drug were as follows:Cmax,691.50 vs 697.30 μg/L;Tmax,20.65 vs 24.10 h;AUC0~∞,148 124 vs 153 782 μg·h/L;t1/2,127.46 vs 131.06 h,respectively.The relative bioavailability was 99.43%.Conclusion The test bicalutamide tablet is bioequivalent to the control formulation.

Key concepts: Bioequivalence, Bicalutamide, Cmax, Bioavailability, Pharmacokinetics, Pharmacology, Medicine, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Bioequivalence of bicalutamide tablet in healthy volunteers — Research Paper | ScholarLens